MDMA Moves from Party Drug Back to Therapy To...

In this episode of Science Quickly, Andrea Thompson, senior desk editor for life sciences at Scientific American, joins host Kendra Pierre-Louis to discuss the recent heat wave in parts of the U.S. We’ll also dive into a recent district court ruling against a decision by the Trum ...  Show more

In this episode of Science Quickly, author Andy Weir joins SciAm’s Bri Kane to talk all things Project Hail Mary—from working with Ryan Gosling on the new film adaptation of the book to building the extraterrestrial character Rocky’s alien world and blending real science with pla ...  Show more

Rick Doblin, psychotherapist and the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), returns to chat about methylenedioxymethamphetamine (MDMA) and its positive effects on PTSD and trauma.Today, Doblin share what MDMA is, how it ...  Show more

In this episode, I discuss Methyl​enedioxy​methamphetamine (MDMA), which is also commonly known as “ecstasy” or “molly,” including how it works in the brain to cause short- and long- term-shifts in emotional processing and its clinical applications for the treatment of post-traum ...  Show more

Once a party drug, ketamine has found its way into modern medicine. 

In the form of recreational ecstasy, the psychoactive drug MDMA carries with it a stigma of wide-eyed ravers, free love and counterculture pharmacological spirituality. But beyond its cultural legacy, MDMA offers a potent therapeutic tool for doctors and therapists -- if we ca ...